Search by Drug Name or NDC

    NDC 57896-0624-12 GERI-LANTA SUPREME CHERRY 400; 135 mg/5mL; mg/5mL Details

    GERI-LANTA SUPREME CHERRY 400; 135 mg/5mL; mg/5mL

    GERI-LANTA SUPREME CHERRY is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Geri-Care Pharmaceuticals, Corp. The primary component is CALCIUM CARBONATE; MAGNESIUM HYDROXIDE.

    Product Information

    NDC 57896-0624
    Product ID 57896-624_09a7c60a-df32-0baa-e063-6394a90a4fcc
    Associated GPIs 48990002301820
    GCN Sequence Number 002667
    GCN Sequence Number Description calcium carb/magnesium hydrox ORAL SUSP 400-135/5 ORAL
    HIC3 D4B
    HIC3 Description ANTACIDS
    GCN 63160
    HICL Sequence Number 001153
    HICL Sequence Number Description CALCIUM CARBONATE/MAGNESIUM HYDROXIDE
    Brand/Generic Generic
    Proprietary Name GERI-LANTA SUPREME CHERRY
    Proprietary Name Suffix n/a
    Non-Proprietary Name calcium carbonate, magnesium hydroxide
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 400; 135
    Active Ingredient Units mg/5mL; mg/5mL
    Substance Name CALCIUM CARBONATE; MAGNESIUM HYDROXIDE
    Labeler Name Geri-Care Pharmaceuticals, Corp
    Pharmaceutical Class Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhi
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number M001
    Listing Certified Through 2024-12-31

    Package

    NDC 57896-0624-12 (57896062412)

    NDC Package Code 57896-624-12
    Billing NDC 57896062412
    Package 355 mL in 1 BOTTLE (57896-624-12)
    Marketing Start Date 2011-03-01
    NDC Exclude Flag N
    Pricing Information N/A